Safe and effective: anti-tumour necrosis factor therapy use in pregnant patients with Crohn disease and ulcerative colitis

865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy

(2015) Uma Mahadevan et al.   GASTROENTEROLOGY

960 Exposure to Anti-TNFα Therapy in the Third Trimester of Pregnancy Is Not Associated With Increased Adverse Outcomes: Results From the PIANO Registry

(2014) Uma Mahadevan et al.   GASTROENTEROLOGY

Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient

(2012) F. M. Habal et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006

(2011) A. Bortoli et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

(2011) Natalie A. Molodecky et al.   GASTROENTEROLOGY

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics

(2010) Uma Mahadevan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

High incidence of inflammatory bowel disease in Australia: A prospective population-based Australian incidence study

(2010) Jarrad Wilson et al.   INFLAMMATORY BOWEL DISEASES

European evidenced-based consensus on reproduction in inflammatory bowel disease

(2010) C. Janneke van der Woude et al.   Journal of Crohns & Colitis

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

(2009) Gert Van Assche et al.   Journal of Crohns & Colitis